Vardhman Acrylics Limited
VARDHACRLC · NSE · Consumer Cyclical
StocksWizard rates Vardhman Acrylics Limited a Strong Buy, scoring 81/100 on our blended model. At ₹44.48 it trades below our blended DCF and relative-multiples fair value of ₹68.71, implying roughly 54% upside to that estimate — we read the stock as undervalued by 54%. Financial health scores 100/100 (grade A). It clears 7 of 10 investability checks, with durability 54, valuation 92 and momentum 92 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹54.97.
Investability checklist
- ✕ROE above 15%11.1%
- –Low debt (D/E < 0.5)
- ✕Positive free cash flow
- ✓Revenue growth > 10%16%
- ✓Earnings growing711%
- ✕Net margin ≥ 10%8.6%
- ✓Current ratio > 1.53.50
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- –Piotroski ≥ 7
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Opportunities
- •Earnings growing (711% YoY).
- •Revenue growing (16% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~55% below our estimated fair value.
About Vardhman Acrylics Limited
Vardhman Acrylics Limited manufactures and supplies acrylic fibers and tows in India. It offers its products under the Varlan brand name. The company was incorporated in 1990 and is headquartered in Ludhiana, India
More in Consumer Cyclical
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.